Additional Charges Against Valeant Pharma (VRX) or Former Execs Cannot Be Ruled Out - Wells Fargo's Maris
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
Valeant Pharma (VRX) Off Lows as Charges Relate to Employee Fraud Versus Company Fraud
November 17, 2016 11:45 AM ESTValeant Pharma (NYSE: VRX) is bouncing off morning lows as the charges against former exec Gary Tanner and CEO the Philidor Andrew Davenport appear more related to individual fraud versus company fraud. Shares of VRX are down 2% after trading down 7%... More
Valeant Pharma (VRX) Comments on Philidor Criminal Complaint; Says Co., Former CEO/CFO Not Yet Charged
November 17, 2016 10:48 AM ESTValeant Pharmaceuticals International, Inc. (NYSE: VRX) learned that a criminal complaint was filed in relation to Philidor. Gary Tanner and Andrew Davenport were charged in the matter. The company, former CEO, former CFO, and current executives have not been charged at this... More
Valeant (VRX) puts active on U.S. Attorney charges against ex-Valeant executive, ex-Philidor CEO
November 17, 2016 9:53 AM ESTValeant Pharma (NYSE: VRX) November 16.50 and 17 puts are active on total put volume of 16K contracts (7K calls) after U.S. Attorney announce charges against ex-Valeant executive, ex-Philidor CEO. November put option implied volatility is at 155, December is at 84; compared to its 52-week range of 53 to 174.
... MoreEx-Valeant executive, ex-pharmacy CEO charged for fraud scheme
November 17, 2016 9:46 AM ESTBy Nate Raymond
NEW YORK (Reuters) - A former Valeant Pharmaceuticals International Inc (NYSE: VRX) executive and the former CEO of mail order pharmacy Philidor Rx Services were arrested on Thursday on charges that they engaged in a multimillion-dollar fraud and kickback scheme.
Federal prosecutors in Manhattan accused Gary Tanner, a ex-senior Valeant director, of secretly working with former Philidor Chief Executive Officer Andrew Davenport to promote the specialty pharmacy's business within the Canadian drugmaker.
The scheme culminated in Valeant agreeing to pay $100 million for the right to buy now-defunct Philidor,... More
New York DOJ Attorney Announces Charges Against Two Former Valeant Pharma (VRX) Execs
November 17, 2016 9:38 AM ESTNew York Southern District DOJ Attorney Preet Bharara announces charges against Gary Tanner, a former executive at Valeant Pharmaceuticals International, Inc., (NYSE: VRX) and Andrew Davenport, the former Chief Executive Officer of Philidor Rx Services LLC, for engaging in a multi-million dollar fraud and... More
Two Valeant (VRX) -Linked Executives Said to be Arrested Thursday - Bloomberg
November 17, 2016 9:36 AM EST(Updated)
Two executives linked to Valeant Pharma (NYSE: VRX) were said to be arrested Thursday, according to Bloomberg. Those arrested included Gary Tanner, former executive at Valeant, and Andrew Davenport, former CEO of Philidor Rx.
... MoreValeant Pharma (VRX) Lower as Philidor Charges Said Imminent
November 17, 2016 9:29 AM ESTValeant Pharma (NYSE: VRX) is modestly lower pre-open on reports charges are coming imminently at Philidor. Shares are down 1%.
... More